Natus Medical (NTUS)
NASDAQ: NTUS
· Real-Time Price · USD
32.96
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM
Natus Medical Revenue Breakdown
Period Ending | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Jun 30, 2017 | Mar 31, 2017 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Sep 30, 2013 | Jun 30, 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurology Products Revenue | 51.39M | 70.05M | 70.45M | 69.06M | 58.74M | 43.51M | 65.32M | 72.19M | 71.6M | 62.39M | 69.79M | 70.41M | 65.95M | 59.29M | 56.27M | 56.75M | 61.22M | 56.67M | 59.4M | 58.63M | 56.29M | 58.69M | 55.77M | 56.49M | 55.35M | 52.78M |
Neurology Products Revenue Growth | -26.64% | -0.58% | +2.03% | +17.57% | +35.00% | -33.39% | -9.52% | +0.83% | +14.76% | -10.60% | -0.88% | +6.76% | +11.24% | +5.36% | -0.85% | -7.30% | +8.03% | -4.60% | +1.33% | +4.16% | -4.09% | +5.23% | -1.26% | +2.05% | +4.88% | n/a |
Newborn Care Products Revenue | 19.39M | 24.47M | 26.35M | 25.94M | 25.71M | 26.92M | 24.23M | 27M | 26.56M | 26.88M | 31.21M | 29.09M | 30.89M | 34.14M | 40.63M | 34.15M | 34.74M | 30.66M | 35.18M | 33.31M | 33.11M | 31.19M | 30.55M | 29.14M | 30.04M | 29.47M |
Newborn Care Products Revenue Growth | -20.76% | -7.11% | +1.57% | +0.89% | -4.48% | +11.08% | -10.27% | +1.66% | -1.18% | -13.88% | +7.30% | -5.84% | -9.51% | -15.98% | +18.97% | -1.68% | +13.31% | -12.85% | +5.61% | +0.61% | +6.16% | +2.08% | +4.85% | -3.00% | +1.92% | n/a |
Other Products Revenue | 11.34M | 19.36M | 19.18M | 19.93M | 18.36M | 14.36M | 19.83M | 24.27M | 27.38M | 25.49M | 29.64M | 31.16M | 31.77M | 28.8M | 27.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Products Revenue Growth | -41.41% | +0.93% | -3.79% | +8.59% | +27.88% | -27.61% | -18.28% | -11.37% | +7.42% | -14.00% | -4.88% | -1.93% | +10.31% | +3.76% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Otometrics Revenue | 37.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Otometrics Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Jun 30, 2018 | Mar 31, 2018 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Foreign Countries Revenue | 49.82M | 75.36M | 41.76M | 45.24M | 47.16M | 69.31M | 39.25M | 33.6M | 41.05M | 79.34M | 49.91M | 52.01M | 48.69M | 55.19M | 59.94M | 55.15M | 59.95M | 63.76M | 28.39M | 28.43M | 30.43M | 64.42M | 32.03M | 31.43M | 34.83M | 36.01M | 33.18M | 33.86M | 37.28M | 33.98M | 34.31M | 37.48M | 39.98M | 33.33M | 26.89M |
Foreign Countries Revenue Growth | -33.88% | +80.43% | -7.69% | -4.06% | -31.97% | +76.60% | +16.80% | -18.13% | -48.27% | +58.98% | -4.03% | +6.81% | -11.77% | -7.93% | +8.68% | -8.00% | -5.98% | +124.58% | -0.14% | -6.57% | -52.77% | +101.13% | +1.90% | -9.76% | -3.28% | +8.55% | -2.01% | -9.18% | +9.71% | -0.98% | -8.45% | -6.24% | +19.95% | +23.95% | n/a |
United States Revenue | 69.97M | n/a | 72.11M | 70.74M | 67.77M | n/a | 63.55M | 51.17M | 68.34M | n/a | 73.55M | 73.53M | 66.07M | 75.47M | 68.67M | 67.08M | 64.71M | n/a | 62.52M | 67.53M | 56.9M | n/a | 62.55M | 60.51M | 54.56M | 58M | 56.7M | 52.47M | 48.35M | n/a | 47.94M | n/a | n/a | n/a | n/a |
United States Revenue Growth | n/a | n/a | +1.95% | +4.37% | n/a | n/a | +24.19% | -25.11% | n/a | n/a | +0.03% | +11.30% | -12.46% | +9.90% | +2.38% | +3.65% | n/a | n/a | -7.42% | +18.68% | n/a | n/a | +3.38% | +10.89% | -5.92% | +2.29% | +8.07% | +8.53% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 42.36M | 41.73M | 41.11M | 42.1M | 43.83M | 40.07M | 38.42M | 33.99M | 43.91M | 47.84M | 45.96M | 44.93M | 50.03M | 45.94M | 49M | 57.12M | 53.32M | 47.98M | 49.87M | 54.51M | 48.23M | 36.91M | 32.57M | 33.16M | 33.08M | 35.45M | 32.53M | 33.76M | 32.29M |
Selling, General, and Administrative Revenue Growth | +1.50% | +1.50% | -2.34% | -3.94% | +9.36% | +4.31% | +13.03% | -22.60% | -8.20% | +4.08% | +2.30% | -10.21% | +8.91% | -6.25% | -14.22% | +7.13% | +11.12% | -3.78% | -8.52% | +13.02% | +30.68% | +13.33% | -1.79% | +0.25% | -6.70% | +9.00% | -3.67% | +4.55% | n/a |
Research and Development Revenue | 13.22M | 13.75M | 14.27M | 14.25M | 14.04M | 14.72M | 14.67M | 14.34M | 17.57M | 18.79M | 14.11M | 12.77M | 13.06M | 15.3M | 15.13M | 15.62M | 15.44M | 13.72M | 11.63M | 13.71M | 12.75M | 10.85M | 7.69M | 7.11M | 7.8M | 8.57M | 7.7M | 7.31M | 6.86M |
Research and Development Revenue Growth | -3.83% | -3.62% | +0.13% | +1.49% | -4.63% | +0.35% | +2.33% | -18.40% | -6.51% | +33.14% | +10.53% | -2.21% | -14.63% | +1.12% | -3.13% | +1.12% | +12.53% | +17.98% | -15.18% | +7.53% | +17.57% | +41.07% | +8.22% | -8.93% | -8.93% | +11.26% | +5.35% | +6.59% | n/a |
Sales and Marketing Revenue | 29.55M | 29.3M | 28.26M | 29.49M | 28.97M | 27.71M | 26.04M | 22.8M | 30.73M | 32.3M | 30.85M | 32.24M | 33.73M | 34.21M | 33.2M | 33.4M | 35.87M | 31.06M | 32.54M | 30.35M | 32.22M | 23.26M | 19.75M | 21.24M | 20.6M | 22.33M | 22.5M | 22.11M | 20.74M |
Sales and Marketing Revenue Growth | +0.87% | +3.66% | -4.16% | +1.78% | +4.53% | +6.45% | +14.18% | -25.80% | -4.85% | +4.69% | -4.31% | -4.43% | -1.39% | +3.03% | -0.60% | -6.89% | +15.49% | -4.54% | +7.19% | -5.78% | +38.52% | +17.78% | -7.02% | +3.11% | -7.77% | -0.73% | +1.75% | +6.59% | n/a |